Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Indenture

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Indenture

Entities:

Immunomedics, Inc.; Bank of New York

Date:

2004

Size:

Preview shows 40KB of 226KB total

Price:

$84

ID:

#274599

 

 

► Financing ► Indentures
► Financial ► Money Center Banks
► Biotech & Drugs ► In Vitro & In Vivo Diagnostic Substances

 

 

Start of Preview


 

IMMUNOMEDICS, INC.,

 

as Issuer

 


 

The Bank of New York,

 

as Trustee

 


 

Up to $13,000,000 Aggregate Principal Amount of

 

3.25% Convertible Senior Notes due 2006

 


 

INDENTURE

 

Dated as of January 20, 2004

 


 



TABLE OF CONTENTS

 

          Page

     ARTICLE I     
     DEFINITIONS AND INCORPORATION BY REFERENCE     

Section 1.1

   Definitions    1

Section 1.2

   Incorporation by Reference of Trust Indenture Act    8

Section 1.3

   Rules of Construction    8

Section 1.4

   Acts of Holders    8
     ARTICLE II     
     THE SECURITIES     

Section 2.1

   Form and Dating    10

Section 2.2

   Execution and Authentication    10

Section 2.3

   Registrar, Paying Agent and Conversion Agent    11

Section 2.4

   Paying Agent to Hold Cash and Securities in Trust    12

Section 2.5

   Holder Lists    12

Section 2.6

   Transfer and Exchange    13

Section 2.7

   Replacement Securities    13

Section 2.8

   Outstanding Securities; Determinations of Holders Action    14

Section 2.9

   Temporary Securities    15

Section 2.10

   Cancellation    15

Section 2.11

   Persons Deemed Owners    15

Section 2.12

   Additional Transfer and Exchange Requirements    16

Section 2.13

   CUSIP Numbers    18

Section 2.14

   Ranking    18

 

ARTICLE III

 

[INTENTIONALLY OMITTED]

 

ARTICLE IV

 

[INTENTIONALLY OMITTED]

 

ARTICLE V

 

PURCHASE AT THE OPTION OF HOLDERS UPON A DESIGNATED EVENT

 

Section 5.1

   Designated Event Put    18

 

-i-


Section 5.2

  

Effect of Designated Event Purchase Notice

   21

Section 5.3

  

Deposit of Designated Event Purchase Price

   21

Section 5.4

  

Securities Purchased in Part

   22

Section 5.5

  

Covenant to Comply with Securities Laws Upon Purchase of Securities

   22

Section 5.6

  

Repayment to the Company

   22
     ARTICLE VI     
     COVENANTS     

Section 6.1

  

Payment of Securities

   23

Section 6.2

  

SEC and Other Reports to the Trustee

   24

Section 6.3

  

Compliance Certificate

   25

Section 6.4

  

Further Instruments and Acts

   25

Section 6.5

  

Maintenance of Office or Agency of the Trustee, Registrar, Paying Agent and Conversion Agent

   25

Section 6.6

  

Delivery of Information Required Under Rule 144A

   25

Section 6.7

  

Waiver of Stay, Extension or Usury Laws

   26

Section 6.8

  

Statement by Officers as to Default

   26
     ARTICLE VII     
     SUCCESSOR CORPORATION     

Section 7.1

  

When Company May Merge or Transfer Assets

   26
     ARTICLE VIII     
     DEFAULTS AND REMEDIES     

Section 8.1

  

Events of Default

   27

Section 8.2

  

Acceleration

   29

Section 8.3

  

Other Remedies

   30

Section 8.4

  

Waiver of Past Defaults

   30

Section 8.5

  

Control by Majority

   30

Section 8.6

  

Limitation on Suits

   30

Section 8.7

  

Rights of Holders to Receive Payment or to Convert

   31

Section 8.8

  

Collection Suit by Trustee

   31

Section 8.9

  

Trustee May File Proofs of Claim

   31

Section 8.10

  

Priorities

   32

Section 8.11

  

Undertaking for Costs

   32

 

-ii-


     ARTICLE IX     
     TRUSTEE     

Section 9.1

  

Duties of Trustee

   33

Section 9.2

  

Rights of Trustee

   34

Section 9.3

  

Individual Rights of Trustee

   35

Section 9.4

  

Trustees Disclaimer

   35

Section 9.5

  

Notice of Defaults

   35

Section 9.6

  

Reports by Trustee to Holders

   36

Section 9.7

  

Compensation and Indemnity

   36

Section 9.8

  

Replacement of Trustee

   37

Section 9.9

  

Successor Trustee by Merger

   38

Section 9.10

  

Eligibility; Disqualification

   38

Section 9.11

  

Preferential Collection of Claims Against Company

   38
     ARTICLE X     
     DISCHARGE OF INDENTURE     

Section 10.1

  

Discharge of Liability on Securities

   38

Section 10.2

  

Repayment to the Company

   38
     ARTICLE XI     
     AMENDMENTS     

Section 11.1

  

Without Consent of Holders

   39

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC